Year: 2025
Type: article
Abstract: The U.S. Supreme Court this month unanimously overturned an appellate court ruling that the Food and Drug Administration (FDA) had acted improperly in denying two companies' applications to market flavored vaping products. The Supreme Court's decision could prove to have greater relevance to the health care regulatory process during the current administration than to the e‐cigarette market.
Source: Alcoholism & Drug Abuse Weekly
DOI: 10.1002/adaw.34481
Author: Gary Enos
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409380517